EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Migrastatic Properties of Selective MMP-2 Inhibitors in Colorectal Cancer: An In Ovo Approach

Nikunj Parekh, Mansi Patel, Praysha Patel, Disha Patel, Kirtan Patel, Krishna Thakkar, Aarti Parmar, Umang Shah, Sahil Panjvani, Samir Patel, Alkeshkumar Kiritbhai Patel

Drug Research · 01.01.2026 · 76 (01) · 5-13

DOI: 10.1055/a-2724-6878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.01.2026. Verfasst von Nikunj Parekh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Matrix Metalloproteinase Inhibitors, Matrix Metalloproteinase 2, Antineoplastic Agents. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Charotar University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer accounts for about 10% of all cancer diagnoses and is the second leading cause of cancer-related death. Until the cancer has progressed to an advanced stage, colorectal cancer typically shows no symptoms. The medications currently utilized to treat colorectal cancer have serious drawbacks. The aim of the study was to evaluate the ability of newly developed synthetic matrix metalloprotease-2 inhibitors to prevent metastases. This study used computational models to evaluate pharmacokinetic characteristics and ligand-binding affinities for preliminary screening. Later, we used the human colorectal cancer cell line SW620 in an in ovo approach to assess its anti-migratory properties. The chorioallantoic membrane was used to transplant tumor cells. In order to assess migrastatic activity in a preclinical model using an in ovo technique, we measured changes in the chick embryo's total body weight, colon length and body weight, complete blood count and histopathology of the colon, liver and stomach. In addition, the histology of the stomach, liver, colon, and chorioallantoic membrane was taken into account while assessing the activity. We discovered that compound N5 ({4-[(3′-amino[1,1′-biphenyl]-4-carbonyl) amino] phenyl~acetic acid) had the best migrastatic action by blocking matrix metalloprotease-2. The new compound showed potential as a matrix metalloprotease-2 inhibitor compared to doxycycline. A more robust platform was needed for further investigation and progress of novel compound towards clinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsMatrix Metalloproteinase InhibitorsMatrix Metalloproteinase 2Antineoplastic AgentsChick EmbryoHumansAnimalsCell Line, TumorCell MovementChorioallantoic Membrane

Substanzen

Matrix Metalloproteinase InhibitorsMatrix Metalloproteinase 2Antineoplastic Agents

Autor:innen und Institutionen

  • Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India.
  • University of Windsor, Windsor, Canada.
  • Department of Histopathology, Vadodara Clinical Laboratory, Vadodara, India.

Förderung

  • Charotar University of Science and Technology

Zitieren

APA

Parekh, N., Patel, M., Patel, P., Patel, D., Patel, K., Thakkar, K., Parmar, A., Shah, U., Panjvani, S., Patel, S., & Patel, A. K. (2026). Evaluation of the Migrastatic Properties of Selective MMP-2 Inhibitors in Colorectal Cancer: An In Ovo Approach. Drug Research, 76(01), 5-13. https://doi.org/10.1055/a-2724-6878

Vancouver

Parekh N, Patel M, Patel P, Patel D, Patel K, Thakkar K, et al. Evaluation of the Migrastatic Properties of Selective MMP-2 Inhibitors in Colorectal Cancer: An In Ovo Approach. Drug Research. 2026;76(01):5-13. doi:10.1055/a-2724-6878

BibTeX
@article{Parekh2026,
  author = {Parekh, Nikunj and Patel, Mansi and Patel, Praysha and Patel, Disha and Patel, Kirtan and Thakkar, Krishna and Parmar, Aarti and Shah, Umang and Panjvani, Sahil and Patel, Samir and Patel, Alkeshkumar Kiritbhai},
  title = {Evaluation of the Migrastatic Properties of Selective MMP-2 Inhibitors in Colorectal Cancer: An In Ovo Approach},
  journal = {Drug Research},
  year = {2026},
  volume = {76},
  number = {01},
  pages = {5--13},
  doi = {10.1055/a-2724-6878}
}
Kostenlos starten →